Labcorp Holdings (LH) Cash from Investing Activities (2009 - 2026)
Labcorp Holdings' (LH) quarterly Cash from Investing Activities came in at -$322.1 million in Q1 2026, up 4.14% year-on-year from -$309.3 million in Q1 2025, and up 17.39% quarter-over-quarter from -$389.9 million in Q4 2025.
Labcorp Holdings (LH) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Labcorp Holdings has disclosed Cash from Investing Activities across 18 years of filings, most recently posting -$322.1 million for Q1 2026.
- Cash from Investing Activities for Q1 2026 came in at -$322.1 million, up 4.14% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.2 billion (up 9.9% YoY), and the FY2025 annual result was -$1.2 billion, up 12.64% from the prior year.
- Cash from Investing Activities came in at -$322.1 million for Q1 2026 at Labcorp Holdings, up from -$389.9 million in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of -$94.1 million in Q2 2025 to a low of -$579.1 million in Q3 2024.
- The 5-year median for Cash from Investing Activities is -$322.1 million (2026), against an average of -$334.2 million.
- Across the five-year window, Cash from Investing Activities plunged 332.85% in 2022 and soared 82.6% in 2023, its largest moves.
- Labcorp Holdings' Cash from Investing Activities stood at -$273.3 million in 2022, then dropped by 11.93% to -$305.9 million in 2023, then jumped by 31.48% to -$209.6 million in 2024, then tumbled by 86.02% to -$389.9 million in 2025, then climbed by 17.39% to -$322.1 million in 2026.
- The last three Cash from Investing Activities figures came in at -$322.1 million (Q1 2026), -$389.9 million (Q4 2025), and -$374.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,010.71 Bn | 30,010.25 Bn | 1.11 Bn | 95.00 Mn |
| 2 | Thermo Fisher Scientific | 179.46 Bn | 176.21 Bn | 7.74 Bn | -8.96 Bn |
| 3 | Danaher | 130.33 Bn | 124.64 Bn | 3.59 Bn | -249.00 Mn |
| 4 | Idexx Laboratories | 44.44 Bn | 44.24 Bn | 722.74 Mn | -33.54 Mn |
| 5 | Agilent Technologies | 37.27 Bn | 35.46 Bn | 990.00 Mn | -77.00 Mn |
| 6 | Iqvia Holdings | 30.70 Bn | 28.73 Bn | 1.36 Bn | -196.00 Mn |
| 7 | Natera | 30.59 Bn | 29.49 Bn | 696.04 Mn | -32.14 Mn |
| 8 | Illumina | 24.86 Bn | 23.71 Bn | 721.00 Mn | -366.00 Mn |
| 9 | Mettler Toledo International | 23.06 Bn | 23.00 Bn | 555.82 Mn | -31.35 Mn |
| 10 | Labcorp Holdings | 22.11 Bn | 21.15 Bn | 1.01 Bn | -322.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -322.10 Mn |
| Mar 31, 2026 | -322.10 Mn |
| Dec 31, 2025 | -389.90 Mn |
| Dec 31, 2025 | -389.90 Mn |
| Sep 30, 2025 | -374.00 Mn |
| Sep 30, 2025 | -374.00 Mn |
| Jun 30, 2025 | -94.10 Mn |
| Jun 30, 2025 | -94.10 Mn |
| Mar 31, 2025 | -336.00 Mn |
| Mar 31, 2025 | -336.00 Mn |
| Dec 31, 2024 | -209.60 Mn |
| Dec 31, 2024 | -209.60 Mn |
| Sep 30, 2024 | -579.10 Mn |
| Sep 30, 2024 | -579.10 Mn |
| Jun 30, 2024 | -185.00 Mn |
| Jun 30, 2024 | -185.00 Mn |
| Mar 31, 2024 | -393.10 Mn |
| Mar 31, 2024 | -393.10 Mn |
| Dec 31, 2023 | -305.90 Mn |
| Dec 31, 2023 | -305.90 Mn |